CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-12 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
| 2026-01-12 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −7,875 | $479.51 | $3.8M | 0 |
| 2026-01-12 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Stock Options 10b5-1 | −14,625 | 82,500 | ||
| 2026-01-12 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Stock Options 10b5-1 | −7,875 | 44,440 | ||
| 2026-01-06 | CAUSEY CHRISTOPHER Director | Option exercise 10b5-1 | +1,000 | $119.76 | $120K | 5,190 |
| 2026-01-06 | CAUSEY CHRISTOPHER Director | Sale 10b5-1 | −1,000 | $510.00 | $510K | 4,190 |
| 2026-01-06 | CAUSEY CHRISTOPHER Director | Option exercise · Stock Option 10b5-1 | −1,000 | 7,320 | ||
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | +14,625 | $117.76 | $1.7M | 14,625 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −697 | $480.68 | $335K | 13,928 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,657 | $481.86 | $798K | 12,271 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −873 | $482.72 | $421K | 11,398 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −697 | $483.80 | $337K | 10,701 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,169 | $485.00 | $567K | 9,532 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,669 | $486.05 | $811K | 7,863 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −856 | $487.40 | $417K | 7,007 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,189 | $488.38 | $581K | 5,818 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −677 | $489.49 | $331K | 5,141 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,659 | $490.11 | $813K | 3,482 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,201 | $491.35 | $590K | 2,281 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,110 | $492.44 | $547K | 1,171 |
Page 162 of 171 · 3,408 trades